Liver transplantation for the treatment of nodular regenerative hyperplasia

Digestive and Liver Disease

Volumn 43, Issue 12, 2011, Pages 929-934

  Manzia, Tommaso Maria ^a   Gravante, Gianpiero ^b   Di Paolo, Daniele ^c   Orlando, Giuseppe ^d   Toti, Luca ^a   Bellini, Maria Irene ^b   Ciano, Paolo ^a   Angelico, Mario ^c   Tisone, Giuseppe ^a  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Liver transplantation; Nodular regenerative hyperplasia; Portal hypertension

Indexed keywords

AGE; ASCITES; AVASCULAR NECROSIS; CLINICAL ASSESSMENT; COCHRANE LIBRARY; CYTOMEGALOVIRUS INFECTION; EMBASE; ESOPHAGUS HEMORRHAGE; ESOPHAGUS VARICES BLEEDING; FOLLOW UP; GENDER; GRAFT SURVIVAL; HEPATIC ENCEPHALOPATHY; HERPES ZOSTER ENCEPHALITIS; HUMAN; LIVER FAILURE; LIVER HYPERPLASIA; LIVER TRANSPLANTATION; MEDLINE; NODULAR REGENERATIVE HYPERPLASIA; PANCREATITIS; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SEPSIS; STOMACH HEMORRHAGE; SURVIVAL RATE; SYSTEMATIC REVIEW;

HUMANS; HYPERPLASIA; LIVER; LIVER DISEASES; LIVER TRANSPLANTATION;

EID: 80055100570     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.04.004     Document Type: Review

References (89)

1. International Working Party Terminology of nodular hepatocellular lesions. Hepatology 1995, 22:983-993.
2. Steiner P.E. Nodular regenerative hyperplasia of the liver. Am J Pathol 1959, 35:943-953.
3. Nakanuma Y. Nodular regenerative hyperplasia of the liver: retrospective survey in autopsy series. J Clin Gastroenterol 1990, 12:460-465.
4. Wanless I.R. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2500 autopsies and a new classification of benign hepatocellular. Hepatology 1990, 11:787-797.
5. Minervini M.I., Ruppert K., Fontes P., et al. Liver biopsy findings from healthy potential living liver donors: reasons for disqualification, silent diseases and correlation with liver injury tests. J Hepatol 2009, 50:501-510.
6. Chawla Y., Dhiman R.K. Intrahepatic portal venopathy and related disorders of the liver. Semin Liver Dis 2008, 28:270-281.
7. Wanless I.R., Godwin T.A., Allen F., et al. Nodular regenerative hyperplasia of the liver in hematologic disorders: a possible response to obliterative portal venopathy. A morphometric study of nine cases with an hypothesis on the pathogenesis. Medicine (Baltimore) 1980, 59:367-379.
8. Farrell G.C. Nodular regenerative hyperplasia. Sleisinger and Fortran's gastrointestinal and liver disease 2002, 1434. Saunders, Philadelphia. 7th ed. M. Feldman, L.S. Friedman, M.H. Sleisinger (Eds.).
9. Shimamatsu K., Wanless I.R. Role of ischemia in causing apoptosis, atrophy, and nodular hyperplasia in human liver. Hepatology 1997, 26:343-350.
10. Arvanitaki M., Adler M. Nodular regenerative hyperplasia of the liver. A review of 14 cases. Hepatogastroenterology 2001, 48:1425-1429.
11. Thiyagarajan T., Gupta A., Limurti J., et al. Education and imaging, hepatobiliary and pancreatic: nodular regenerative hyperplasia of the liver. J Gastroenterol Hepatol 2009, 24:1801.
12. Washington K., Lane K.L., Meyers W.C. Nodular regenerative hyperplasia in partial hepatectomy specimens. Am J Surg Pathol 1993, 17:1151-1158.
13. Bernard P.H., Le Bail B., Cransac M., et al. Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol 1995, 22:495-499.
14. Sciot R., Staessen D., Van Damme B., et al. Incomplete septal cirrhosis: histopathological aspects. Histopathology 1988, 13:593-603.
15. Mikkelsen W.P., Edmondson H.A., Peters R.L., et al. Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg 1965, 162:602-620.
16. Bioulac-Sage P., Le Bail B., Bernard P.H., et al. Hepatoportal sclerosis. Semin Liver Dis 1995, 15:329-339.
17. Ibarrola C., Collina F. Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate. Histopathology 2003, 42:251-264.
18. Laharie D., Vergniol J., Biolac-Sage P., et al. Usefulness of noninvasive tests in nodular regenerative hyperplasia of the liver. Eur J Gastroenterol Hepatol 2010, 22:487-493.
19. Ames J.T., Federle M.P., Chopra K. Distinguishing clinical and imaging features of nodular regenerative hyperplasia and large regenerative nodules of the liver. Clin Radiol 2009, 64:1190-1195.
20. von Herbay A., Westendorff J., Gregor M. Contrast-enhanced ultrasound with SonoVue: differentiation between benign and malignant focal liver lesions in 317 patients. J Clin Ultrasound 2010, 38:1-9.
21. Reshamwala P.A., Kleiner D.E., Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology 2006, 44:7-14.
22. Ibarrola C., Colina F. Clinicopathological features of nine cases of non-cirrhotic portal hypertension: current definitions and criteria are inadequate. Histopathology 2003, 42:251-264.
23. Nakanuma Y., Hoso M., Sasaki M., et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology 1996, 28:195-204.
24. Naber A.H., Van Haelst U., Yap S.H. Nodular regenerative hyperplasia of the liver: an important cause of portal hypertension in non-cirrhotic patients. J Hepatol 1991, 12:94-99.
25. Colina F., Alberti N., Solis J.A., et al. Diffuse nodular regenerative hyperplasia of the liver (DNRH). A clinicopathologic study of 24 cases. Liver 1989, 9:253-265.
26. Stromeyer F.W., Ishak K.G. Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol 1981, 12:60-71.
27. Ueno S., Tanabe G., Sueyoshi K., et al. Hepatic hemodynamics in a patient with nodular regenerative hyperplasia. Am J Gastroenterol 1996, 91:1012-1015.
28. Mallet V.O., Varthaman A., Lasne D., et al. Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. AIDS 2009, 23:1511-1518.
29. Hillaire S., Bonte E., Denninger M.H., et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut 2002, 51:275-280.
30. Al-Mukhaizeem K.A., Rosenberg A., Sherker A.H. Nodular regenerative hyperplasia of the liver: an under-recognized cause of portal hypertension in hematological disorders. Am J Hematol 2004, 75:225-230.
31. Klein S.K., Slim E.J., de Kruif M.D., et al. Is chronic HIV infection associated with venous thrombotic disease? A systematic review. Neth J Med 2005, 63:129.
32. Gris J.C., Toulon P., Brun S., et al. The relationship between plasma microparticles, protein S and anticardiolipin antibodies in patients with human immunodeficiency virus infection. Thromb Haemost 1996, 76:38-45.
33. Devarbhavi H., Abraham S., Kamath P.S. Significance of nodular regenerative hyperplasia occurring de novo following liver transplantation. Liver Transpl 2007, 13:1552.
34. Kakar S., Kamath P.S., Burgart L.J. Sinusoidal dilatation and congestion in liver biopsy: is it always due to venous outflow impairment?. Arch Pathol Lab Med 2004, 128:901-904.
35. Kondo F. Benign nodular hepatocellular lesions caused by abnormal hepatic circulation: etiological analysis and introduction of a new concept. J Gastroenterol Hepatol 2001, 16:1319-1328.
36. Dinh M.H., Stosor V., Rao S.M., et al. Cryptogenic liver disease in HIV-seropositive men. HIV Med 2009, 10:447-453.
37. Mallet V., Blanchard P., Verkarre V., et al. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007, 21:187-192.
38. Garvey L.J., Thomson E.C., Lloyd J., et al. Nodular regenerative hyperplasia is a new cause of chronic liver disease in HIV-infected patients. AIDS 2007, 21:1494-1495.
39. Arey B., Markov M., Ravi J., Prevette E., et al. Nodular regenerative hyperplasia of liver as a consequence of ART. AIDS 2007, 21:1066-1068.
40. Sandrine P.F., Sylvie A., Andre E., et al. Nodular regenerative hyperplasia: a new serious antiretroviral drugs side effect?. AIDS 2007, 21:1498-1499.
41. Maida I., Garcia-Gasco P., Sotgiu G., et al. Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome. Antivir Ther 2008, 13:103-107.
42. Maida I., Nunez M., Rios M.J., et al. Severe liver disease associated with prolonged exposure to antiretroviral drugs. J Acquir Immune Defic Syndr 2006, 42:177-182.
43. Saifee S., Joelson D., Braude J., et al. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin Gastroenterol Hepatol 2008, 6:1167-1169.
44. Tateo M., Sebagh M., Bralet M.P., et al. A new indication for liver transplantation: nodular regenerative hyperplasia in human immunodeficiency virus-infected patients. Liver Transpl 2008, 14:1194-1198.
45. Chang P.E., Miquel R., Blanco J.L., et al. Idiopathic portal hypertension in patients with HIV infection treated with highly active antiretroviral therapy. Am J Gastroenterol 2009, 104:1707-1714.
46. Kovari H., Ledergerber B., Peter U., et al. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin Infect Dis 2009, 49:626-635.
47. Schiano T.D., Kotler D.P., Ferran E., et al. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol 2007, 102:2536-2540.
48. Podevin P., Spiridon G., Terris B., et al. Nodular regenerative hyperplasia of the liver after IL-2 therapy in an HIV-infected patient. AIDS 2006, 20:313-315.
49. Gonzalez-Alegre M.T., Guerra-Vales J.M., Martinez G., et al. Nodular regenerative hyperplasia of the liver and Hodgkin's disease: a case report. Acta Gastroenterol Belg 2004, 67:358-360.
50. Malamut G., Ziol M., Suarez F., et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol 2008, 48:74-82.
51. Sekiya M., Sekigawa I., Hishikawa T., et al. Nodular regenerative hyperplasia of the liver in systemic lupus erythematosus. The relationship with anticardiolipin antibody and lupus anticoagulant. Scand J Rheumatol 1997, 26:215-217.
52. Gonzalez-Alvaro I., Carmona-Ortell L., Amigo-Etxenagusia A., et al. Nodular regenerative hyperplasia of the liver and primary Sjogren's syndrome. J Rheumatol 1994, 21:168-169.
53. Hussain N., Feld J.J., Kleiner D.E., et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 2007, 45:675-683.
54. Voinchet O., Degott C., Scoazec J.Y., et al. Peliosis hepatis, nodular regenerative hyperplasia of the liver, and lightchain deposition in a patient with Waldenstrom's macroglobulinemia. Gastroenterology 1988, 95:482-486.
55. Ward C., Lucas M., Piris J., et al. Abnormal liver function in common variable immunodeficiency disorders due to nodular regenerative hyperplasia. Clin Exp Immunol 2008, 153:331-337.
56. Leung V.K., Loke T.K., Luk I.S., et al. Nodular regenerative hyperplasia of the liver associated with systemic lupus erythematosus: three cases. Hong Kong Med J 2009, 15:139-142.
57. Harris M., Rash R.M., Dymock I.W. Nodular, non-cirrhotic liver associated with portal hypertension in a patient with rheumatoid arthritis. J Clin Pathol 1974, 27:963-966.
58. McMahon R.F., Babbs C., Warnes T.W. Nodular regenerative hyperplasia of the liver, CREST syndrome and primary biliary cirrhosis: an overlap syndrome?. Gut 1989, 30:1430-1433.
59. Gonzalez-Alvaro I., Carmona-Ortell L., Amigo-Etxenagusia A., et al. Nodular regenerative hyperplasia of the liver and primary Sjogren's syndrome. J Rheumatol 1994, 21:168-169.
60. Blendis L.M., Parkinson M.C., Shilkin K.B., et al. Nodular regenerative hyperplasia of the liver in Felty's syndrome. Q J Med 1974, 43:25-32.
61. Breen D.P., Marinaki A.M., Arenas M., et al. Pharmacogenetic association with adverse drug reactions to azathioprine immunosuppressive therapy following liver transplantation. Liver Transpl 2005, 11:826-833.
62. Gane E., Portmann B., Saxena R., et al. Nodular regenerative hyperplasia of the liver graft after liver transplantation. Hepatology 1994, 20:88-94.
63. Krasinskas A. The significance of nodular regenerative hyperplasia in the transplanted liver. Liver Transpl 2007, 13:1496-1497.
64. Buster E.H., van Vuuren H.J., Zondervan P.E., et al. Thiopurine-methyltransferase and inosine triphosphate pyrophosphatase polymorphism in a liver transplant recipient developing nodular regenerative hyperplasia on low-dose azathioprine. Eur J Gastroenterol 2008, 20:68-72.
65. Buffet C., Cantarovitch M., Pelletier G., et al. Three cases of nodular generative hyperplasia of the liver following renal transplantation. Nephrol Dial Transplant 1998, 3:327-330.
66. de Boer N.K., Mulder C.J., van Bodegraven A.A. Nodular regenerative hyperplasia and thiopurines: the case for level-dependent toxicity. Liver Transpl 2005, 11:1300-1301.
67. van den Broek M.A., Olde Damink S.W., Driessen A., et al. Nodular regenerative hyperplasia secondary to neoadjuvant chemotherapy for colorectal liver metastates. Case Report Med 2009, 45795.
68. Hubert C., Sempoux C., Hormans Y., et al. Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?. Liver Int 2007, 27:938-943.
69. Sebagh M., Farges O., Samuel D., et al. Nodular regenerative hyperplasia of the liver following orthotopic liver transplantation. Transplant Proc 1995, 27:2510-2511.
70. Morla R.M., Ramos-Casals M., Garcia-Carrasco M., et al. Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature. Lupus 1999, 8:160-163.
71. Levy S., Diebold M.D., Nguyen P., et al. Nodular regenerative hyperplasia of the liver associated with a factor V Leiden mutation. Eur J Gastroenterol Hepatol 1998, 10:721.
72. Buchel O., Roskams T., Van Damme B., et al. Nodular regenerative hyperplasia, portal vein thrombosis, and avascular hip necrosis due to hyperhomocysteinaemia. Gut 2005, 54:1021-1023.
73. de Ledinghen V., Levillain P., Besson I., et al. Nodular regenerative hyperplasia of the liver and Turner syndrome. Gastroenterol Clin Biol 1994, 18:898-899.
74. Thevenot T., Dhote R., Tulliez M., et al. Turner syndrome and nodular regenerative hyperplasia of the liver. Ann Med Intern 1998, 149:295-296.
75. Cazals-Hatem D., Vilgrain V., Genin P., et al. Arterial and portal circulation and parenchymal changes in Budd-Chiari syndrome: a study in 17 explanted livers. Hepatology 2003, 37:510-519.
76. Bihl F., Janssens F., Boehlen F., et al. Anticoagulant therapy for nodular regenerative hyperplasia in a HIV-infected patient. BMC Gastroenterol 2010, 10:6.
77. Dumortier J., Bizollon T., Scoazec J.Y., et al. Orthotopic liver transplantation for idiopathic portal hypertension: indications and outcome. Scand J Gastroenterol 2001, 36:417-422.
78. Krasinskas A.M., Eghtesad B., Kamath P.S., et al. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl 2005, 11:627-634.
79. Loinaz C., Colina F., Musella M., et al. Orthotopic liver transplantation in four patients with portal hypertension and noncirrhotic nodular liver. Hepatogastroenterology 1998, 45:1787-1794.
80. Radomski J.S., Chojnacki K.A., Mortiz M.J., et al. Results of liver transplantation for nodular regenerative hyperplasia. Am Surg 2000, 66:1067-1070.
81. Dumortier J., Boillot O., Chevallier M., et al. Familial occurrence of nodular regenerative hyperplasia of the liver: a report on three families. Gut 1999, 45:289-294.
82. Krishna M., Keaveny A.P., Genco P.V., et al. Clinicopathological review of 18 cases of liver allografts lost due to bile duct syndrome. Transpl Proc 2005, 37:2221-2223.
83. Jawaid Q., Saeed Z.A., Di Bisceglie A.M., et al. Biliary-venous fistula complicating transjugular intrahepatic portosystemic shunt presenting with recurrent bacteremia, jaundice, anemia and fever. Am J Transpl 2003, 3:1604-1607.
84. Elariny H.A., Mizrahi S.S., Hayes D.H., et al. Nodular regenerative hyperplasia: a controversial indication for orthotopic liver transplantation. Transpl Int 1994, 7:309-313.
85. McDonald J.A., Painter D.M., Gallagher N.D., et al. Nodular regenerative hyperplasia mimicking cirrhosis of the liver. Gut 1990, 31:725-727.
86. Bonaccorsi-Riani E., Lerut J.P. Liver transplantation and vascular tumors. Transpl Int 2010, 23:686-691.
87. Ravaioli M., Grazi G., Dazzi A., et al. Survival benefit after liver transplantation: a single European center experience. Transplantation 2009, 88:826-834.
88. Merion R.M., Schaubel D.E., Dykstra D.M., et al. The survival benefit of liver transplantation. Am J Transpl 2005, 5:307-313.
89. Perkins J.D., Halldorson J.B., Bakthavatsalam R., et al. Should liver transplantation in patients with model for end-stage liver disease scores < or = 14 be avoided? A decision analysis approach. Liver Transpl 2009, 15:242-254.